# clm_AD43BA302B07

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: shares_outstanding  
value: 956,592,393 shares  
valid_from: 2021-10-22  
valid_to: 2022-02-18  
published: 2021-10-27  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_D784DBD622DB  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company shares outstanding: 956,592,393 shares", as of 2021-10-22 (until 2022-02-18). Claim clm_AD43BA302B07, https://asof.is/claim/clm_AD43BA302B07, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000216/0000059478-21-000216-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-10-27  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947821000216/0000059478-21-000216-index.htm (primary, SEC EDGAR 10-Q Q3 FY2021, published 2021-10-27)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | shares_outstanding | 956,580,893 shares | valid 2021-07-30 to 2021-10-22 | conf 0.95 | superseded | superseded_by [clm_AD43BA302B07](/claim/clm_AD43BA302B07.md) | [clm_EA59F20B3B9B](/claim/clm_EA59F20B3B9B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.